Mauna Kea Technologies SA (EPA:ALMKT)
France · Delayed Price · Currency is EUR 0.1410
-0.0046 (-3.16%)
Sep 29, 2026, 5:35 PM CET
Mauna Kea Technologies Company Description
Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia.
It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients.
The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA
| Country | France |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 59 |
| CEO | Alexandre Loiseau |
Contact Details
Address: 9, rue d'Enghien Paris, 75010 France | |
| Phone | 33 1 48 24 03 45 |
| Website | maunakeatech.com |
Stock Details
| Ticker Symbol | ALMKT |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010609263 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Loiseau Ph.D. | Co-Founder, Chief Executive Officer and Chairman |
| Come de La Tour du Pin | Chief Financial Officer |
| Nathalie Lecoq | Chief Operating Officer |
| François Lacombe Ph.D. | Chief Scientific Officer |
| Daryl Donatelli | President of U.S. and Head of Global Marketing |